Oberweis Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-360,700
| Closed | -$9.88M | – | 226 |
|
|
2024
Q3 | $9.88M | Hold |
360,700
| – | – | 0.51% | 74 |
|
|
2024
Q2 | $8.82M | Buy |
+360,700
| New | +$8.82M | 0.54% | 73 |
|
|
2019
Q1 | – | Sell |
-8,230
| Closed | -$239K | – | 217 |
|
|
2018
Q4 | $239K | Buy |
8,230
+2,800
| +52% | +$81.3K | 0.05% | 183 |
|
|
2018
Q3 | $250K | Sell |
5,430
-700
| -11% | -$32.2K | 0.05% | 199 |
|
|
2018
Q2 | $229K | Buy |
+6,130
| New | +$229K | 0.06% | 210 |
|
|
2018
Q1 | – | Sell |
-9,884
| Closed | -$339K | – | 238 |
|
|
2017
Q4 | $339K | Buy |
+9,884
| New | +$339K | 0.08% | 195 |
|